Work

Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2003-12-4264

Authors: David A. Rizzieri, Gamal Akabani, Michael R. Zalutsky, R. Edward Coleman, Scott D. Metzler, James E. Bowsher, Bonnie Toaso, Elizabeth Anderson, Anand Lagoo, Steve Clayton, Charles N. Pegram, Joseph O. Moore, Jon P. Gockerman, Carlos DeCastro, Cristina Gasparetto, Nelson J. Chao, Darell D. Bigner

Institutions: Duke University, Duke Medical Center, Duke University Health System

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: G2392992127, G4946238614, SMALL-SCALE DOSIMETRY OF BONE USING HISTOLOGICAL IMAGING, Update of Duke Research SPECT System, G951266999

OpenAlex ID: W2160545140

FWCI: 4.802

Cites: 40

Cited by: 47

Related to: 10